These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36258023)

  • 1. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.
    Dowling DJ; Barman S; Smith AJ; Borriello F; Chaney D; Brightman SE; Melhem G; Brook B; Menon M; Soni D; Schüller S; Siram K; Nanishi E; Bazin HG; Burkhart DJ; Levy O; Evans JT
    Sci Rep; 2022 Oct; 12(1):16860. PubMed ID: 36258023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants.
    Dowling DJ
    Immunohorizons; 2018 Jul; 2(6):185-197. PubMed ID: 31022686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
    Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
    Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis: Where did we go wrong and what can we do about it?
    Locht C
    J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.
    Allen AC; Mills KH
    Expert Rev Vaccines; 2014 Oct; 13(10):1253-64. PubMed ID: 25017925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
    Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
    Front Immunol; 2019; 10():1520. PubMed ID: 31333656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
    Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
    Front Immunol; 2022; 13():878832. PubMed ID: 35493458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the
    Aibani N; Patel P; Buchanan R; Strom S; Wasan KM; Hancock REW; Gerdts V; Wasan EK
    Mol Pharm; 2022 Jun; 19(6):1814-1824. PubMed ID: 35302764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine.
    Bruno C; Agnolon V; Berti F; Bufali S; O'Hagan DT; Baudner BC
    Eur J Pharm Biopharm; 2016 Aug; 105():1-8. PubMed ID: 27224856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
    van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
    Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
    van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
    Front Immunol; 2018; 9():51. PubMed ID: 29416544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.
    Dowling DJ; van Haren SD; Scheid A; Bergelson I; Kim D; Mancuso CJ; Foppen W; Ozonoff A; Fresh L; Theriot TB; Lackner AA; Fichorova RN; Smirnov D; Vasilakos JP; Beaurline JM; Tomai MA; Midkiff CC; Alvarez X; Blanchard JL; Gilbert MH; Aye PP; Levy O
    JCI Insight; 2017 Mar; 2(6):e91020. PubMed ID: 28352660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New acellular pertussis-containing paediatric combined vaccines.
    Pines E; Barrand M; Fabre P; Salomon H; Blondeau C; Wood SC; Hoffenbach A
    Vaccine; 1999 Mar; 17(13-14):1650-6. PubMed ID: 10194818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
    Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.